Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Babies were mostly born healthy from fathers who took finasteride, but some pregnancies ended early; more research is needed.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Some epilepsy drugs can cause reproductive and cosmetic side effects in women and affect pregnancy, but most women still have healthy babies.

Minoxidil is effective for hair growth and safe for long-term use.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

PCOS is a hormonal disorder causing symptoms like excess hair, acne, irregular periods, and fertility issues.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Women with PCOS have a similar chance of getting pregnant using assisted reproductive treatment as those without PCOS.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Older age, higher BMI, and family history of diabetes increase the risk of gestational diabetes in pregnant women.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Some chemicals in cosmetics may harm pregnant individuals, fetuses, and newborns, and should be avoided unless necessary.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Metformin is safe in early pregnancy for women with PCOS and may reduce certain risks.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Pregnancy can cause unique skin issues, some of which may risk the mother and baby's health and need careful treatment.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.